title: [The influence of a tocolytic therapy with Th 1165 a on the excretion of total oestrogens in urine in the second half of pregnancy (author's transl)].
mesh_terms: D000328:Adult; D001724:Birth Weight / Q000187:drug effects; D001827:Body Height / Q000187:drug effects; D004967:Estrogens / Q000652:urine*; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous; D008297:Male; D009921:Metaproterenol / Q000008:administration & dosage / Q000627:therapeutic use*; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D010636:Phenols / Q000008:administration & dosage / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D013566:Sympathomimetics / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D004967:Estrogens; D010636:Phenols; D013566:Sympathomimetics; D009921:Metaproterenol
vernacular_title: Der Einflubb einer totolytischen Behandlung mit Th 1165 a auf die Ausscheidung der Gesamtöstrogene im Urin in der zweiten Hälfte der Schwangerschaft.